{"id":327012,"date":"2026-10-26T16:45:17","date_gmt":"2026-10-26T11:15:17","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=327012"},"modified":"2026-10-26T16:45:17","modified_gmt":"2026-10-26T11:15:17","slug":"cardiac-and-gastro-brands-specialist-latin-america-generics-seller-and-contract-formulations-maker-stocks-roadmap-summit-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/cardiac-and-gastro-brands-specialist-latin-america-generics-seller-and-contract-formulations-maker-stocks-roadmap-summit-list\/","title":{"rendered":"3 Cardiac and Gastro Brands Specialist, Latin America Generics Seller and Contract Formulations Maker Stocks With a Strong Future Roadmap: JB Chemicals and Pharmaceuticals, Caplin Point Laboratories and Innova Captab"},"content":{"rendered":"

JB Chemicals and Pharmaceuticals, Caplin Point Laboratories and Innova Captab: ROE of 12.9% to 17.9% and FY22 to FY26 revenue CAGR of 14.3% to 19.5%. Prices as of 23 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three brand, Latin America and contract pharma stocks to watch are JB Chemicals and Pharmaceuticals, Caplin Point Laboratories and Innova Captab. Their return on equity ranges from 12.9% to 17.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.3% to 19.5%. Caplin Point Laboratories has the highest return on equity at 17.9%, while Innova Captab has the fastest revenue growth at 19.5% a year. Prices are based on the 23 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

Brand, Latin America and contract pharma stocks bring together companies with a visible plan for the years ahead. JB Chemicals and Pharmaceuticals, Caplin Point Laboratories and Innova Captab cover a cardiac and gastro brands specialist, a Latin America generics seller and a contract formulations maker.<\/p>\n

This list covers three brand, Latin America and contract pharma stocks with complete current figures: JB Chemicals and Pharmaceuticals, Caplin Point Laboratories and Innova Captab. Every figure comes from the latest reported financials and the 23 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n